HIV Pre-Exposure Prophylaxis: Scoping Review
DOI:
https://doi.org/10.33448/rsd-v12i11.43674Keywords:
Human immunodeficiency; Pre-exposure prophylaxis; Pharmaceutical care; Pharmaceutical services; Pharmaceutical attention.Abstract
Introduction: The lack of provision of HIV pre-exposure prophylaxis in medication dispensing units means that populations eligible for the use of prophylaxis are deprived of access, contributing to an increased risk of acquiring the HIV virus. Objective: To map potential strategies for pharmaceutical services and/or pharmaceutical care for Pre-exposure Prophylaxis to the Human Immunodeficiency Virus. Methodology: Scope review guided by the acronym PCC, where Participants: Pharmacists; Concept: Pre-exposure prophylaxis to the Human Immunodeficiency Virus; Context: Medium Complexity Health Care. Results: There are records that pharmaceutical services and/or pharmaceutical care for Pre-exposure Prophylaxis to the Human Immunodeficiency Virus reduce new cases of HIV, as does the offer of PrEP by pharmaceutical professionals. Conclusion: The findings show that pharmaceutical services and/or pharmaceutical care for Pre-exposure Prophylaxis to the Human Immunodeficiency Virus are robust.
References
Alohan, D.I., Evans, G., Sanchez, T., Harrington, K. R. V., Quamina, A., Young, H. N., & Crawford, N. D. (2023). Examining pharmacies' ability to increase pre-exposure prophylaxis access for black men who have sex with men in the United States. Journal of the American Pharmacists Association: JAPhA, 63(2), 547–554. https://doi.org/10.1016/j.japh.2022.11.004
Aragão, D. J., & Tavares, M. (2017). Como Preparar um Relato de caso Clínico. Cadernos UniFOA, 4(9):59–61. https://doi.org/10.47385/cadunifoa.v4.n9.939
Aromataris, E., & Munn, Z. (Editors). (2020). JBI Manual for Evidence Synthesis. JBI. https://synthesismanual.jbi.global. https://doi.org/10.46658/JBIMES-20-01
Bastos, J. L. D., & Duquia, R. P. (2007). Um dos delineamentos mais empregados em epidemiologia: estudo transversal. Scientia Medica, 17(4):229-232. Umdosdelineamentosmaisempregadosemepidemiologia (1).pdf
Bellman, R., Mohebbi, S., Nobahar, N., Parizher, J., & Apollonio, D. E. (2022). An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies. Journal of the American Pharmacists Association: JAPhA, 62(1), 370–377.e3. https://doi.org/10.1016/j.japh.2021.08.001
Brasil. (2022). Ministério da Saúde. Conselho Nacional de Saúde. Resolução nº 674, de 06 de maio de 2022. Dispõe sobre a tipificação da pesquisa e a tramitação dos protocolos de pesquisa no Sistema CEP/CONEP. Brasília. Distrito Federal.
Brasil. (2020). Ministério da Saúde. Boletim Epidemiológico. HIV/Aids/2020. Número Especial. Brasília-DF. Dezembro/2020. http://www.aids.gov.br/pt-br/pub/2020/ boletim-epidemiologico-hivaids-2020
Brasil. (2020). Ministério da Saúde. Casos de Aids diminuem no Brasil. Boletim Epidemiológico sobre a Doença aponta queda na Taxa de Detecção de Aids no País desde 2012. Brasília-DF. http://www.aids.gov.br/pt-br/noticias/casos-de-aids-diminu em-no-brasil
Brasil. (2019). Ministério da Saúde. Relatório de Implantação PrEX HIV de janeiro a dezembro de 2018. Brasília. Distrito Federal. http://www.aids.gov.br/pt-br/pub/2019/relatorio-de-implantacao-da-profilaxia-pos-exposicao-prep-hiv
Brasil. (2021). Ministério da Saúde. Secretaria de Vigilância em Saúde. Protocolo Clínico e Diretrizes Terapêuticas para Profilaxia Pós-Exposição (PEP) de risco à infecção pelo HIV, IST e Hepatites Virais. Brasília. Distrito Federal. http://www.aids.gov.br/pt-br/pub/2015/protocolo-clinico-e-diretrize-terapeuticas-para-profilaxia-pos-exposicao-pep-de-risco
Brasil. (2021). Ministério da Saúde. Sistema de Controle Logístico de Medicamentos (SICLOM). Brasília. Distrito Federal. http://www. aids.gov.br/pt-br/gestores/sistemas-de-informacao/sistema-de-controle-logistico-de-medicamentos-siclom
Bunting, S. R., Feinstein, B. A., Bertram, C., Hazra, A., Sheth, N. K., & Garber, S. S. (2023). Effects of knowledge and implicit biases on pharmacy students' decision-making regarding pre-exposure prophylaxis for HIV prevention: A vignette-based experimental study. Currents in pharmacy teaching & learning, 15(2), 139–148. https://doi.org/10.1016/j.cptl.2023.02.019
Burns, C. M., Endres, K., Derrick, C., Cooper, A., Fabel, P., Okeke, N. L., Ahuja, D., Corneli, A., & McKellar, M. S. (2023). A survey of South Carolina pharmacists' readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis. Journal of the American College of Clinical Pharmacy, JACCP, 6(4), 329-338. https://doi.org/10.1002/jac5.1773
Cernasev, A., Melton, T. C., Jasmin, H., & Barenie, R. E. (2023). A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP). Pharmacy, 11(1), 9. https://doi.org/10.3390/pharmacy11010009
Cernasev, A., Barénie, R. E., Wofford, B. R., Dourado, J., & Walker, C. (2023). Empowering Tennessee Pharmacists to Initiate PrEP Using Collaborative Pharmacy Practice Agreements. Clin. Pratique, 13, 280- 287. https://doi.org/10.3390/clinpract13010025
Chaves, J. C., Lo Prete, A. C., Soler, O. & Azevedo-Ribeiro, C. H. M. (2021). Intervenções farmacêuticas e seus desfechos em portadores de HIV/AIDS em atendimento de média complexidade. Revista Eletrônica Acervo Saúde, 13(4), 1-14. https://doi.org/10.25248/REAS.e43 90.2021
Conselho Nacional de Secretarias Municipais de Saúde (CONASEMS). (2023). Instrumento de referência dos serviços farmacêuticos na Atenção Básica. Chaves, E. S., Hamida, H. M., Junqueira, M. (Coord.). 68p. Brasília. Distrito Federal.
Cordeiro, L., & Baldini, S.C. (2020). Revisão de escopo: potencialidades para a síntese de metodologias utilizadas em pesquisa primária qualitativa. BIS. Boletim do Instituto de Saúde, 20(2), 3743. docs.bvsalud.org/biblioref/2019/10/1021863/bis-v20n2-sintese-de-evidencias-qualitativas-37-43.pdf
Crawford, N. D., Josma, D., Morris, J., Hopkins, R., & Young, H. N. (2020). Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men. Journal of the American Pharmacists Association: JAPhA, 60(4), 602-608. https://doi.org/10.1016/j.japh.2019.12.003
Farmer, E. K., Koren, D. E., Cha, A., Grossman, K., & Cates, D. W. (2019). The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis. AIDS patient care and STDs, 33(5), 207-213. https://doi.org/10.1089/apc.2018.0294
Greenwell, K., Fugit, R., Nicholson, L., & Wright, J. A. (2023). Retrospective Comparison of HIV Pre-exposure Prophylaxis (PrEP) Outcomes Between a Pharmacist-led Telehealth Clinic and In-person Clinic in a Veteran Population. AIDS Behav. https://doi.org/10.1007/s10461-023-04084-2
Havens, J. P., Scarsi, K. K., Sayles, H., Klepser, D. G., Swindells, S., & Bares, S. H. (2019). Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States. Open forum infectious diseases, 6(10), ofz365. https://doi.org/10.1093/ofid/ofz365
Khosropour, C. M., Backus, K. V., Means, A. R., Beauchamps, L., Johnson, K., Golden, M. R., & Mena, L. (2020). A Pharmacist-Led, Same-Day, HIV Pre-Exposure Prophylaxis Initiation Program to Increase PrEP Uptake and Decrease Time to PrEP Initiation. AIDS patient care and STDs, 34(1), 1-6. https://doi.org/10.1089/apc.2019.0235
Koester, K. A., Saberi, P., Fuller, S. M., Arnold, E. A., & Steward, W. T. (2020). Attitudes about community pharmacy access to HIV prevention medications in California. Journal of the American Pharmacists Association: JAPhA, 60(6), e179-e183. https://doi.org/10.1016/j.japh.2020.06.005
Li, D. H., Benbow, N., Keiser, B., Mongrella, M., Ortiz, K., Villamar, J., Gallo, C., Deskins, J. S., Xavier Hall, C. D., Miller, C., Mustanski, B., & Smith, J. D. (2022). Determinants of Implementation for HIV Pre-exposure Prophylaxis Based on an Updated Consolidated Framework for Implementation Research: A Systematic Review. Journal of acquired immune deficiency syndromes (1999), 90(S1), S235-S246. https://doi.org/10.1097/QAI.0000000000002984
Lopez, M. I., Cocohoba, J., Cohen, S. E., Trainor, N., Levy, M. M., & Dong, B. J. (2020). Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health. Journal of the American Pharmacists Association: JAPhA, 60(1), 138-144. https://doi.org/10.1016/j.japh.2019.06.021
McCree, D. H., Byrd, K. K., Johnston, M., Gaines, M., & Weidle, P. J. (2020). Roles for Pharmacists in the "Ending the HIV Epidemic: A Plan for America" Initiative. Public health reports (Washington, D.C.: 1974), 135(5), 547–554. https://doi.org/10.1177/0033354920941184
Meyerson, B. E., Dinh, P. C., Agley, J. D., Hill, B. J., Motley, D. N., Carter, G. A., Jayawardene, W., & Ryder, P. T. (2019). Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP). AIDS Behav, 23, 1925-1938. https://doi.org/10.1007/s10461-018-02383-7
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group. (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7), e1000097. 10.1371/journal.pmed1000097
Moraes Filho, D. S., Martins, L. H. C., Costa, R. N., Queiroz, L. M. D., Passos, M. M. B., & Soler, O. (2022). Pharmacists’ perception of their technical-assistance and managerial-technical functions in private community pharmacies. Research, Society and Development, 11(2), e33611225743. https://doi.org/10.33448/rsd-v11i2.25743
Murad, M. H., Asi, N., Alsawas, M., & Alahdab, F. (2016). New evidence pyramid. Evid Based Med, 21(4), 125-127. 10.1136/ebmed-2016-110401. untitled (bmj.com)
Mussi, R. F. F., Flores, F. F., & Almeida, C. B. (2021). Pressupostos para a elaboração de relato de experiência como conhecimento científico. Práxis Educacional, Vitória da Conquista, 17(48), 60-77. 10.22481/praxisedu.v17i48.9010.
Nakambale, H. N., Roche, S. D., Mogere, P., Omollo, V., Kuo, A. P., Stergachis, A., Baeten, J. M., Bukusi, E., Ngure, K., Mugambi, M. L., & Ortblad, K. F. (2023). Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: An analysis of routine data. Frontiers in reproductive health, 5, 1023568. https://doi.org/10.3389/frph.2023.1023568
Okoro, O., & Hillman, L. (2018). HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health. Journal of the American Pharmacists Association: JAPhA, 58(4), 412-420.e3. https://doi.org/10.1016/j.japh.2018.04.007
Oliveira, M. A., Vellarde, G. C., & Sá, R. A. M. (2015). Entendendo a pesquisa clínica III: estudos de coorte. FEMINA. 43(3), 105-110. a5116.pdf (bvs.br)
Oliveira, T. C., Vieira, H. K. S., Elmescany, S. B., Gonçalves, S. T., Santos, V. R. C., & Soler, O. (2021). Interventions applied to the prescription, use and administration of medications as strategic factors for patient safety: systematic review. Research, Society and Development, 10(17), e195101724601. https://doi.org/10.33448/rsd-v10i17.24601
Peters, M. D. J. et al. (2020). Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth;18(10):2119-26. https://doi.org/10.11124/JBIES-20-00167
Porto, F., & Gurgel, J. L. (2018). Sugestão de roteiro para avaliação de um artigo científico. Rev Bras Ciênc Esporte, 40(2), 111-116. https://doi.org/10.1016/j.rbce.2017.12.002
Przybyla, S. M., Parks, K., Bleasdale, J., Sawyer, J., & Morse, D. (2019). Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students. Currents in pharmacy teaching & learning, 11(4), 352-360. https://doi.org/10.1016/j.cptl.2019.01.011
Shea, B. J., Grimshaw, J. M., Wells, G. A., Boers, M., Andersson, N., Hamel, C., Porter, A. C., Tugwell, P., Moher, D., & Bouter, L. M. (2007). Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 15(7), 10.
Thiese, M. S. (2014). Observational and interventional study design types; an overview. Biochem Med (Zagreb), 24, 199-210. Observational and interventional study design types; an overview - Biochemia Medica (biochemia-medica.com)
Tricco, A. C. et al. (2018). Prisma Extension for Scoping Reviews Prisma-ScR): checklist and explanation. Ann Intern Med, 169(7), 467-73. https://doi.org/10.7326/M18-0850
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D., Horsley, T., Weeks, L., Hempel, S. et al. (2018). Prisma extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med.,169(7), 467-473. 10.7326/M18-0850.
Tung, E. L., Thomas, A., Eichner, A., & Shalit, P. (2018). Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care. Sexual health, 15(6), 556-561. https://doi.org/10.1071/SH18084
Wilby, K. J., & Smith, A. J. (2020). A Narrative Review of Continuing Professional Development Needs for Pharmacists with Respect to Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV). Pharmacy 8(2), 84. https://doi.org/10.3390/pharmacy8020084
Zhao, A., Dangerfield, D. T., Nunn, A., Patel, R., Farley, J. E., Ugoji, C. C., & Dean, L. T. (2022). Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review. AIDS and behavior, 26(5), 1377-1392. https://doi.org/10.1007/s10461-021-03494-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Hoberdan da Silva Monteiro; Luana Melo Diogo de Queiroz; Orenzio Soler
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
